| Literature DB >> 22905101 |
Manuel Dehnert1, Volker Fingerle, Christiane Klier, Thomas Talaska, Martin Schlaud, Gérard Krause, Hendrik Wilking, Gabriele Poggensee.
Abstract
BACKGROUND: Lyme borreliosis (LB) caused by spirochetes of the Borrelia burgdorferi sensu lato complex is the most common tick-borne disease in the northern hemisphere. Data on the distribution and on risk factors in Germany are sketchy. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 22905101 PMCID: PMC3419690 DOI: 10.1371/journal.pone.0041321
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Categorisation of samples tested for anti-Borrelia IgG according to the ELISA and line blot test.
*LB = Lyme borreliosis.
Stratified seroprevalence of IgG antibodies against B. burgdorferi detected by ELISA in children and adolescents aged 1 to 17 years and results of weighted bivariate logistic regression analysis of potential risk factors for seropositivity, 2003–2006, Germany.
| n | Prevalence | 95% CI | OR | 95% CI | p-Value | |
|
| ||||||
| Female (n = 6,147) | 274 | 4.1 | 3.6–4.8 | 1 | ||
| Male (n = 6,467) | 357 | 5.5 | 4.8–6.3 | 1.37 | 1.15–1.63 | 0.001 |
|
| ||||||
| West (n = 8,312) | 405 | 4.7 | 4.1–5.4 | 1 | ||
| East (n = 4,302) | 226 | 5.6 | 4.7–6.6 | 1.20 | 0.96–1.50 | 0.100 |
| North (n = 3,317) | 146 | 4.4 | 3.6–5.5 | 1.06 | 0.80–1.39 | 0.689 |
| Middle (n = 5,557) | 257 | 4.2 | 3.6–4.9 | 1 | ||
| South (n = 3,740) | 228 | 5.8 | 4.8–7.0 | 1.41 | 1.09–1.83 | 0.009 |
|
| ||||||
| 1–2 (n = 898) | 13 | 1.3 | 0.74–2.3 | 0.44 | 0.24–0.81 | 0.009 |
| 3–6 (n = 2,379) | 80 | 2.9 | 2.3–3.8 | 1 | ||
| 7–10 (n = 3,059) | 150 | 5.1 | 4.2–6.1 | 1.75 | 1.28–2.40 | 0.001 |
| 11–13 (n = 2,825) | 140 | 4.6 | 3.7–5.6 | 1.57 | 1.11–2.22 | 0.010 |
| 14–17 (n = 3,453) | 248 | 7.1 | 6.2–8.2 | 2.52 | 1.88–3.38 | <0.001 |
|
| ||||||
| No (n = 10,622) | 588 | 5.5 | 4.9–6.1 | 1 | ||
| Yes (n = 1,953) | 40 | 1.9 | 1.4–2.6 | 0.33 | 0.24–0.44 | <0.001 |
|
| ||||||
| Rural area (n = 2,782) | 184 | 7.1 | 5.6–8.9 | 1.96 | 1.44–2.67 | <0.001 |
| Small town (n = 3,348) | 182 | 5.4 | 4.5–6.4 | 1.47 | 1.13–1.90 | 0.004 |
| Mid-sized town (n = 3,683) | 156 | 3.9 | 3.1–5.0 | 1.05 | 0.77–1.43 | 0.758 |
| Metropolitan (n = 2,801) | 109 | 3.7 | 3.1–4.5 | 1 | ||
|
| ||||||
| No pet (n = 6,374) | 283 | 4.2 | 3.6–4.9 | 1 | ||
| Any pet (n = 5,982) | 336 | 5.5 | 4.8–6.3 | 1.34 | 1.10–1.62 | 0.003 |
|
| ||||||
| No (n = 10,346) | 510 | 4.7 | 4.2–5.3 | 1 | ||
| Yes (n = 1,978) | 106 | 5.4 | 4.4–6.6 | 1.15 | 0.92–1.43 | 0.225 |
|
| ||||||
| No (n = 9,963) | 460 | 4.4 | 3.9–5.0 | 1 | ||
| Yes (n = 2,361) | 156 | 6.7 | 5.6–8.0 | 1.56 | 1.25–1.94 | <0.001 |
|
| ||||||
| No (n = 10,224) | 503 | 4.7 | 4.2–5.3 | 1 | ||
| Yes (n = 2,132) | 116 | 5.4 | 4.3–6.6 | 1.14 | 0.90–1.44 | 0.272 |
unweighted.
Combined ELISA and line blot test results: Stratified seroprevalence of IgG antibodies against B. burgdorferi in children and adolescents aged 1 to 17 years and results of weighted bivariate logistic regression analysis of potential risk factors for seropositivity, 2003–2006, Germany.
| n | Prevalence | CI 95% | OR | CI 95% | p-Value | |
|
| ||||||
| Female (n = 6,101) | 215 | 3.3 | 2.8–3.8 | 1 | ||
| Male (n = 6,419) | 300 | 4.7 | 4.1–5.4 | 1.48 | 1.22–1.80 | <0.001 |
|
| ||||||
| West (n = 8,248) | 334 | 3.9 | 3.4–4.5 | 1 | ||
| East (n = 4,272) | 181 | 4.5 | 3.7–5.5 | 1.17 | 0.91–1.49 | 0.219 |
| North (n = 3,294) | 119 | 3.6 | 2.8–4.5 | 1.03 | 0.76–1.37 | 0.866 |
| Central (n = 5,522) | 206 | 3.5 | 2.9–4.1 | 1 | ||
| South (n = 3,704) | 190 | 4.9 | 4.1–5.9 | 1.44 | 1.10–1.88 | 0.007 |
|
| ||||||
| 1–2 (n = 893) | 4 | 0.4 | 0.13–1.2 | 0.17 | 0.06–0.51 | 0.002 |
| 3–6 (n = 2,364) | 61 | 2.3 | 1.7–3.2 | 1 | ||
| 7–10 (n = 3,033) | 119 | 4.1 | 3.3–5.0 | 1.79 | 1.24–2.59 | 0.002 |
| 11–13 (n = 2,809) | 119 | 4.0 | 3.2–4.9 | 1.74 | 1.18–2.55 | 0.005 |
| 14–17 (n = 3,421) | 212 | 6.2 | 5.3–7.1 | 2.77 | 1.93–3.98 | <0.001 |
|
| ||||||
| No (n = 10,622) | 486 | 4.6 | 4.1–5.2 | 1 | ||
| Yes (n = 1,953) | 26 | 1.3 | 0.84–1.9 | 0.26 | 0.18–0.39 | <0.001 |
|
| ||||||
| Rural area (n = 2,745) | 141 | 5.7 | 4.6–7.0 | 1.98 | 1.45–2.71 | <0.001 |
| Small town (n = 3,322) | 153 | 4.5 | 3.7–5.5 | 1.57 | 1.16–2.11 | 0.003 |
| Mid-sized town (n = 3,666) | 136 | 3.5 | 2.7–4.5 | 1.19 | 0.84–1.68 | 0.322 |
| Metropolitan (n = 2,787) | 85 | 2.9 | 2.3–3.7 | 1 | ||
|
| ||||||
| No pet (n = 6,323) | 216 | 3.3 | 2.8–3.9 | 1 | ||
| Any pet (n = 5,940) | 289 | 4.8 | 4.2–5.5 | 1.46 | 1.19–1.80 | <0.001 |
|
| ||||||
| No (n = 10,268) | 412 | 3.9 | 3.4–4.4 | 1 | ||
| Yes (n = 1,964) | 91 | 4.8 | 3.9–5.9 | 1.25 | 0.99–1.59 | 0.062 |
|
| ||||||
| No (n = 9,885) | 361 | 3.5 | 3.1–4.0 | 1 | ||
| Yes (n = 2,347) | 142 | 6.2 | 5.2–7.4 | 1.56 | 1.25–1.94 | <0.001 |
|
| ||||||
| No (n = 10,149) | 412 | 4.0 | 3.5–4.5 | 1 | ||
| Yes (n = 2,114) | 93 | 4.2 | 3.3–5.2 | 1.05 | 0.81–1.35 | 0.709 |
unweighted.
Results of weighted multivariable logistic regression analysis of potential risk factors for ELISA and combined ELISA and line blot seropositivity (n = 12,297 after exclusion of participants with missing data).
| ELISA | Combined ELISA and line blot results | |||||
| OR | CI 95% | p-value | OR | CI 95% | p-value | |
|
| ||||||
| Female | 1 | 1 | ||||
| Male | 1.27 | 1.06–1.53 | 0.010 | 1.35 | 1.10–1.66 | 0.004 |
|
| ||||||
| Female | 1.06 | 1.03–1.09 | <0.001 | 1.07 | 1.03–1.11 | <0.001 |
| Male | 1.11 | 1.08–1.14 | <0.001 | 1.13 | 1.09–1.16 | <0.001 |
|
| ||||||
| No | 1 | 1 | ||||
| Yes | 0.35 | 0.25–0.47 | <0.001 | 0.28 | 0.19–0.42 | <0.001 |
|
| ||||||
| Rural area/small town | 1.30 | 1.03–1.63 | 0.026 | 1.2 | 0.95–1.52 | 0.129 |
| Mid-sized town/Metropolitan | 1 | 1 | ||||
|
| ||||||
| North | 1.03 | 0.79–1.36 | 0.814 | 0.99 | 0.74–1.33 | 0.949 |
| Central | 1 | 1 | ||||
| South | 1.30 | 1.01–1.67 | 0.044 | 1.34 | 1.03–1.75 | 0.028 |
|
| ||||||
| No | 1 | 1 | ||||
| Yes | 1.30 | 1.04–1.63 | 0.024 | 1.50 | 1.19–1.90 | 0.001 |
at mean age of 10.5 years.